Efficacy and safety of neoadjuvant chemotherapy containing anti-angiogenic drugs, immunotherapy, or PARP inhibitors for ovarian cancer
-
Published:2024-02
Issue:
Volume:194
Page:104238
-
ISSN:1040-8428
-
Container-title:Critical Reviews in Oncology/Hematology
-
language:en
-
Short-container-title:Critical Reviews in Oncology/Hematology
Author:
Bao WanyingORCID,
Li Zhengyu
Subject
Oncology,Hematology